Easily-detected biomarker predicts clinical progression of COVID-19, respiratory outcomes
Japanese-European research team discovers novel genetic mitochondrial disorder
16 April 2021Know the signs of rare blood clot linked with J & J vaccine
16 April 2021Easily-detected biomarker predicts clinical progression of COVID-19, respiratory outcomes
Researchers at the University of Rome Tor Vergata have demonstrated for the first time an elevated expression of the HERV-W ENV protein in the blood cells of COVID-19 patients, particularly in T-lymphocytes, important cells of the immune response against viruses and bacteria. In COVID-19 patients, the protein was correlated to inflammation and alteration of the activation and exhaustion of the immune response.
